Wei Qiu, PhD



Associate Professor,  Cancer Biology; Surgical Research

CBCC 338
Office: 708-327-8191

Laboratory Website: 
Qiu Laboratory Website




Research Focus Areas

  • Mechanisms of tumorigenesis in hepatocellular carcinoma (HCC)
  • Mechanisms of therapeutic resistance in HCC
  • Pathogenesis of alcoholic liver disease

Our laboratory is interested in understanding the molecular mechanisms involving hepatocellular carcinoma (HCC) and alcoholic liver disease (ALD). More specifically, using molecular and cell biology techniques, state-of-the-art cell imaging, transgenic and knockout mouse models, and clinical samples, we investigate molecular signaling pathways that drive or mediate HCC and ALD development. Our ultimate goal is to identify novel therapeutic strategies and reagents to prevent and treat HCC and ALD. In addition, we are also interested in studying the resistance mechanisms of FDA-approved targeted therapies for HCC, which shall improve the efficacy of these drugs in treating HCC.

Departmental Program:  Cancer Cell Biology and Signaling

Education / Training:
PhD:   Chinese Academy of Sciences-Beijing,  Beijing, China
Postdoctoral Fellow:  University of Pittsburgh, Pittsburgh, PA  USA

Wei Qiu Publications